Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

<p>Abstract</p> <p>Background</p> <p>In an international, randomized Phase III trial ipilimumab demonstrated a significant overall survival benefit in previously treated advanced melanoma patients. This report summarizes health-related quality of life (HRQL) outcomes fo...

Full description

Bibliographic Details
Main Authors: Revicki Dennis A, van den Eertwegh Alfons JM, Lorigan Paul, Lebbe Celeste, Linette Gerald, Ottensmeier Christian H, Safikhani Shima, Messina Marianne, Hoos Axel, Wagner Samuel, Kotapati Srividya
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Health and Quality of Life Outcomes
Subjects:
Ipilimumab
Randomized clinical trial
EORTC QLQ-C30
Advanced melanoma
Health-related quality of life
Online Access:http://www.hqlo.com/content/10/1/66

Internet

http://www.hqlo.com/content/10/1/66

Similar Items